ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 139 filers reported holding ACCELERON PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.27 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $84,209,000 | -5.2% | 671,041 | +2.5% | 0.09% | -14.0% |
Q1 2021 | $88,809,000 | -11.8% | 654,887 | -16.8% | 0.11% | -18.3% |
Q4 2020 | $100,737,000 | +21.9% | 787,380 | +7.2% | 0.13% | +1.6% |
Q3 2020 | $82,665,000 | +523.7% | 734,608 | +158.1% | 0.13% | +344.8% |
Q1 2019 | $13,255,000 | +7.9% | 284,624 | +0.9% | 0.03% | -6.5% |
Q4 2018 | $12,282,000 | -49.0% | 282,015 | -32.9% | 0.03% | -39.2% |
Q3 2018 | $24,070,000 | -0.0% | 420,580 | -15.2% | 0.05% | -12.1% |
Q2 2018 | $24,077,000 | +19.3% | 496,218 | -3.8% | 0.06% | +16.0% |
Q1 2018 | $20,179,000 | -3.2% | 516,073 | +5.1% | 0.05% | -7.4% |
Q4 2017 | $20,844,000 | -11.3% | 491,141 | -22.0% | 0.05% | -19.4% |
Q3 2017 | $23,504,000 | +38.7% | 629,807 | -5.2% | 0.07% | +28.8% |
Q2 2017 | $16,942,000 | -1.3% | 664,145 | +2.4% | 0.05% | -7.1% |
Q1 2017 | $17,167,000 | +28.0% | 648,533 | +23.4% | 0.06% | +12.0% |
Q4 2016 | $13,415,000 | -21.1% | 525,649 | +11.8% | 0.05% | -21.9% |
Q3 2016 | $17,013,000 | -31.6% | 470,106 | -35.4% | 0.06% | -34.0% |
Q2 2016 | $24,885,000 | +1040.5% | 727,427 | +744.9% | 0.10% | +870.0% |
Q1 2016 | $2,182,000 | -48.0% | 86,100 | 0.0% | 0.01% | -44.4% |
Q4 2015 | $4,198,000 | +173.3% | 86,100 | +39.5% | 0.02% | +157.1% |
Q3 2015 | $1,536,000 | -6.6% | 61,700 | +7.5% | 0.01% | 0.0% |
Q2 2015 | $1,644,000 | +15.2% | 57,400 | +11.2% | 0.01% | +16.7% |
Q1 2015 | $1,427,000 | -68.5% | 51,600 | -55.6% | 0.01% | -70.0% |
Q4 2014 | $4,527,000 | +228.3% | 116,204 | +154.8% | 0.02% | +185.7% |
Q3 2014 | $1,379,000 | +5.4% | 45,600 | +18.4% | 0.01% | +16.7% |
Q2 2014 | $1,308,000 | – | 38,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |